Rotator cuff injury
Conditions
Interventions
ISTB group:Bupivacaine liposomes 2.5ml+0.5% levobupivacaine 2.5ml will be injected between the three branches of the upper trunk
ISB group:Bupivacaine liposome 7.5ml +0.5% levobupivacaine 7.5ml will be injected between the C5 and C6 nerve roots
Sponsors
the Second Affiliated Hospital & Yuying Children's Hospital, Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.eletive arthroscopic rotator cuff repair of shoulder 2.18-65 years old 3.American Society of Anesthesiologists (ASA) Grade I or II
Exclusion criteria
Exclusion criteria: Cannot sign informed consent for this study; Communication barriers; Combined with severe obstructive or restrictive lung disease; Body Mass Index (BMI) >35 kg/m2; Coagulation disorders; Liver or kidney failure; Be pregnant; Local anesthetic allergy; History of chronic opioid use (such as morphine hydrochloride sustained-release tablets, oxycodone hydrochloride sustained-release tablets, fentanyl transdermal patches, etc.); Surgical history of neck or supraclavicular fossa on the operative side; Sensory and motor disorders of the upper extremity on the operative side; Large rotator cuff tear (tear > 5 cm; Involved 2 or more tendon tears)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24h post-operative resting NRS pain score;The incidence of hemidiaphragm paralysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Resting pain score and opioid consumption at each observation time point;Changes in pulmonary function and pulse oxygen saturation;Sensory and motor block duration;Satisfaction with analgesia;Adverse reactions and neurological complications; | — |
Countries
China
Contacts
Public ContactWu Hong
the Second Affiliated Hospital & Yuying Children's Hospital, Wenzhou Medical University
Outcome results
None listed